DOTmed HealthCare Business News: Q&A with Dennis Durmis, senior vice president, Head of Americas Region, Bayer Radiology

08.10.18

The FDA ignited a debate across the medical equipment landscape when it opened a docket in 2016 aimed at better understanding third-party service. That investigation culminated in May with the publication of the FDA’s findings.

Some imaging stakeholders have praised the FDA’s report and see it as a conclusion to a long debate, while others think the report leaves the industry with more questions than answers, and more work needs to be done.

HealthCare Business News spoke to Dennis Durmis, senior vice president, Head of Americas Region, Bayer Radiology, to find out why he believes legislative action is needed in order to pick up where the FDA left off, ensuring safe medical device service for patients in the U.S.

Click here to see the original article on the DOTmed HealthCare Business News website.